Oriental Aromatics Limited

Basic Materials — Specialty Chemicals · NSE

₹634.00+₹54.85 (+9.47%)

DalalBaazaar Score

36 / 100

🔴 Weak

Verdict

CAUTION

Risk

High

Driven by negative free cash flow, micro-cap size, which brings thin liquidity, a very high earnings multiple, which leaves little margin for disappointment.

In simple words: The business is earning a fairly low return on the money invested in it, with both sales and profits growing well. Cash generation is currently the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 6:07 pm

Caution warranted. Multiple fundamental metrics — flagged in red below — point to either valuation stretch, leverage risk, or weakening profitability. This doesn't mean avoid the stock outright, but it does mean the burden of proof is on the growth story to justify the current price.

Understanding the Business

Company site ↗

The 60-second version of Oriental Aromatics Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Oriental Aromatics Limited, together with its subsidiaries, manufactures and sells fragrances, flavours, specialty aroma ingredients, and camphor and terpene chemicals in India.

IndustrySpecialty Chemicals

SectorBasic Materials

Employees768

Annual revenue₹1,024 Cr

How does it make money?

Turns over ₹1,024 Cr a year. Of every ₹100 of sales, about ₹0 reaches shareholders as profit, with ₹7 left at the operating level before interest, tax and depreciation. Each of its 768 employees supports ₹1.33 Cr of revenue a year, the signature of a capital- or asset-led business.

EBITDA margin7.5%

Net margin0.3%

Revenue / employee₹1.33 Cr

Who are its competitors?

The closest listed comparisons in its industry are ASIAN PAINTS LIMITED, PIDILITE INDUSTRIES LTD, SRF LTD, UPL LIMITED. These are the companies its valuation and returns are measured against elsewhere in this report.

ASIAN PAINTS LIMITEDP/E 46.9x · ROE 22.3%

PIDILITE INDUSTRIES LTDP/E 57.8x · ROE 24.4%

SRF LTDP/E 33.8x · ROE 15.4%

UPL LIMITEDP/E 21.5x · ROE 6.1%

What is its competitive advantage?Little sign of one

Returns on capital of 6.1% are at or below what the capital likely costs. That is the financial pattern of a business competing largely on price, where advantage has to come from execution rather than position.

ROCE6.1%

ROE0.5%

Peer median ROE22.3%

What has been driving growth?

Profit has moved mainly because margins changed, not because the business sold much more. Over 3 years revenue moved +21% while net margin moved -86% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+21%

Margin effect-86%

DalalBaazaar Score

36/ 100

Weak

Weighted across six categories. Every point is explained below.

✗ Revenue CAGR of only 6.6% — barely ahead of inflation
✗ Profit has declined at 44.9% a year
✗ Profit is compounding slower than revenue — margins are being squeezed as the business grows

Quality vs. Valuation

Company Quality

36/ 100

Weak

How good the business is, ignoring the share price entirely.

Valuation

26/ 100

Expensive

What you are being asked to pay, ignoring how good the business is.

Weak on business quality and not cheap enough to compensate.

Historical Valuation

Current P/E

401.3x

3Y Median

65.5x

40 monthly readings · mean 130.3x · range 23.4x–646.9x

Sector Median

40.4x

median of 4 sector peers

⚠️Current valuation is approximately 513% above its 3y median of 65.5x. Paying more than usual needs a reason — faster growth, a better balance sheet, or a re-rating you believe in.

⚠️Against its sector it trades 894% above the peer median of 40.4x.

vs. its own history

Expensive

65.5x median over 40 months · +513%

vs. sector peers

Expensive

40.4x median of 4 peers · +894%

vs. generic bands

Expensive

Above 35x

P/E (Trailing)

401.3x

P/B

3.21x

EV/EBITDA

32.9x

PEG

—

Dividend Yield

0.08%

What's Good / What's Bad

🟢 What's Going Well1

Consistently profitable
Profitable in every one of the last 4 reported years.

🔴 What Needs Attention3

Debt is rising
Total debt is up 74% over 3 years — worth checking what it funded.
Free cash flow is negative
The business is not currently covering its capital spending from operations.
Valuation above its historical average
At 401.3x the stock trades 513% above its own median of 65.5x.

Red Flags

5 items require attention · 2 high · 3 watch

🔴Debt has risen sharplyFinancial
Total debt is up 74% over 3 years, from ₹231 Cr to ₹403 Cr.
🔴Thin interest coverageFinancial
Operating profit covers interest only 1.3x — little room if earnings dip.
🟡Interest coverage is deterioratingFinancial
Cover has fallen from 3.0x to 1.3x.
🟡Free cash flow is negativeFinancial
Free cash flow was -₹9 Cr in the latest year.
🟡Profit is decliningFinancial
Net profit is down 83% over 3 years.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Earnings have proved durable
Profitable in every one of the last 4 reported years. Consistency lowers the risk that any single bad year is structural rather than cyclical.

🔴 Bear CaseWhat could go wrong?

The debt load needs earnings to hold up
Debt is 5.3x EBITDA. At that level a downturn in earnings turns a manageable balance sheet into a refinancing problem, and lenders get paid before shareholders.
The price already assumes success
The stock trades 513% above its own median multiple. At this level the business has to deliver just to stand still, and a stumble is repriced twice — lower earnings on a lower multiple.
Growth barely outpaces inflation
Revenue compounding at 6.6% a year is close to the rate prices rise, so the business is gaining little ground in real terms. That leaves the share price dependent on a re-rating rather than on earnings growth.
Earnings are hard to forecast
Profit has swung sharply from year to year, so any single year — good or bad — is a weak guide to the next. Cyclical earnings deserve lower multiples for that reason.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1EBITDA margin holds above 5%✓ 7.5%
Two points below today's level — enough room for noise, tight enough to catch real compression.
2Debt / EBITDA falls below 3x✗ 5.3x
Already stretched, so this is a reduction target rather than a level to hold. Around 3x is where lenders typically start attaching conditions.
3Free cash flow remains positive✗ -₹9 Cr
Profit that never becomes cash eventually stops being profit.
4Interest cover stays above 3x✗ 1.3x
How much operating profit can fall before interest stops being comfortably covered.
5Revenue growth stays above 5% a year✓ 6.6% CAGR
Latest reported year was 15.2%. The bar is set below the established compounding rate, so ordinary variation does not trip it.

Investment Checklist

5 / 11 checks passed

✗ Strong return on equity (ROE ≥ 15%)
✗ Strong return on capital employed (ROCE ≥ 15%)
✗ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✓ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✓ Profit growing year-over-year
✗ Not trading at an extreme valuation (P/E < 40x)
✗ Not buying right at the 52-week high
✓ Short-term technical trend isn't bearish

Price history

Quick Metrics

3 good · 4 neutral · 4 weak

Market Cap

₹2,134 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

401.3x

Expensive

Expensive — verify against sector peers

P/B Ratio

3.21x

Fair

Moderate premium to the company's book value

EPS (TTM)

₹1.58

Profitable

Profitable on a per-share basis

ROE

0.5%

Weak

Weak capital efficiency

ROCE

6.1%

Weak

Low return on total capital employed

Debt/Equity

0.61x

Moderate

Moderate leverage

Revenue Growth (YoY)

15.2%

Healthy

Healthy top-line growth

Profit Growth (YoY)

400.0%

Healthy

Profits growing at a healthy clip

Dividend Yield

0.08%

Modest

Small cash return — most of the return has to come from the price

Free Cash Flow

-₹9 Cr

Cash burning

Spending more cash than the operations bring in

More Metrics

CMP

₹634

Operating Margin

4.6%

Weak

Thin margins leave little room for error

Net Margin

0.5%

Weak

Very little revenue reaches the bottom line

Current Ratio

1.59

Comfortable

Healthy short-term liquidity

Beta (vs Nifty)

0.74

Defensive

Steadier than the market

52W Range Position

100%

Near high

Near its 52-week high

Technical Snapshot

SMA 20 / SMA 50

536.8 / 472.5

Bullish alignment (short > long)

Price vs SMA 200

Above

Long-term uptrend

RSI (14)

73.9

Overbought zone

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹846 Cr	₹832 Cr	₹923 Cr	₹1,024 Cr	+6.6%
EBITDA	₹59 Cr	₹53 Cr	₹97 Cr	₹77 Cr	+8.9%
EBITDA Margin	7.0%	6.4%	10.5%	7.5%	—
PAT (Net Profit)	₹20 Cr	₹9 Cr	₹34 Cr	₹3 Cr	-44.9%
EPS	₹5.87	₹2.71	₹10.2	₹0.98	-44.9%
ROE	3.2%	1.4%	5.2%	0.5%	—
ROCE	5.8%	4.7%	9.3%	6.1%	—
Total Debt	₹231 Cr	₹206 Cr	₹353 Cr	₹403 Cr	+20.3%
Free Cash Flow	-₹69 Cr	₹42 Cr	-₹122 Cr	-₹9 Cr	—

🟢 Revenue has grown at 6.6% a year over 3 years.

🟢 EBITDA has grown at 8.9% a year over 3 years.

🟡 EBITDA Margin has held roughly flat at 7.5% over 3 years.

🔴 PAT (Net Profit) has shrunk at 44.9% a year over 3 years.

🔴 EPS has shrunk at 44.9% a year over 3 years.

🔴 ROE has fallen from 3.2% to 0.5% over 3 years (-2.7 pts).

🟡 ROCE has held roughly flat at 6.1% over 3 years.

🔴 Total Debt has grown at 20.3% a year over 3 years.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹1,194 Cr

Total Liabilities

₹530 Cr

Total Debt

₹403 Cr

Cash & Equivalents

₹13 Cr

Operating Cash Flow

₹2 Cr

Capex

-₹12 Cr

Shareholding (proxy)

Institutional Holding

0.0%

Insider Holding

76.5%

Corporate Actions

Dividend Rate

₹0.5

Ex-Dividend Date

05 Aug 2026

Peer Comparison

Company	P/E	ROE
ASIAN PAINTS LIMITED	46.9x	22.3%
PIDILITE INDUSTRIES LTD	57.8x	24.4%
SRF LTD	33.8x	15.4%
UPL LIMITED	21.5x	6.1%

Recent News

1 positive2 mixed3 general

Oriental Aromatics Ltd. Share Price Rise Streak in Chemicals

Univest, 16 OctPrice move

🟡Mixed / dependsA price move, which is not by itself a change in the business. Worth finding the cause before reading it as either good or bad.

Oriental Aromatics Share Price and Technical Outlook

Kalkine India, 15 Oct

Price Band Hitters, October 15, 2026 at 3:30 PM IST

HDFC Sky, 15 Oct

Oriental Aromatics Ltd Upgraded to Hold as Technicals and Financials Improve

MarketsMojo, 16 OctAnalyst view

🟢Potentially positiveAn analyst opinion changing, which moves the price without changing the business.

Compare CAMPH.& ALL with

Equitymaster, 17 Oct

Oriental Aromatics - FIIs raised stakes in these 12 smallcap stocks in Q1; shares surge up to 123%

The Economic Times, 31 AugPrice move

🟡Mixed / dependsA price move, which is not by itself a change in the business. Worth finding the cause before reading it as either good or bad.

Watch Items

Trading very close to its 52-week high — momentum-driven entries here carry more mean-reversion risk.
Cross-check against the company's latest quarterly filing / investor presentation before acting.
RSI is in overbought territory — momentum entries here carry more short-term pullback risk.

DalalBaazaar Thesis

🔴Business QualityWeak7.5/20

🟡Financial HealthAdequate9.2/20

🔴GrowthWeak5.7/20

🔴ProfitabilityWeak4.5/15

🔴ValuationDemanding4.9/15

🔴RiskHigh4.1/10

Weak on the fundamentals

Poor scores on business quality without a price low enough to compensate. There is no obvious argument for owning this over a stronger company at a similar valuation. 2 high-severity red flags sit above this conclusion and should be read first.

This thesis breaks if

✓EBITDA margin holds above 5%7.5%
✗Debt / EBITDA falls below 3x5.3x
✗Free cash flow remains positive-₹9 Cr
✗Interest cover stays above 3x1.3x
✓Revenue growth stays above 5% a year6.6% CAGR